Cerevel Therapeutics Holdings, Inc. Quarterly Assets in USD from Q4 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly Assets history and growth rate from Q4 2019 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Assets for the quarter ending March 31, 2024 was $1.13B, a 21.2% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.13B +$197M +21.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.24B +$225M +22.2% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $822M -$272M -24.8% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $894M +$298M +49.9% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $930M +$312M +50.4% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $1.02B +$329M +47.7% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.09B +$360M +49.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $597M +$206M +52.6% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 $619M +$210M +51.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $689M +$244M +54.7% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $733M +$583M +387% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $391M +$240M +159% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $408M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $445M +$324M +269% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $151M Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $151M Jun 30, 2020 10-Q 2020-08-14
Q4 2019 $121M Dec 31, 2019 10-K 2021-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.